Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cerebellar magnetization transfer ratio and its relationship to clinical outcomes in radiologically isolated syndrome and multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same author

A more optimistic outlook about disease-modifying therapies and depressive symptoms in multiple sclerosis: A cross-sectional analysis.

Journal of affective disorders·2026
Same author

Increased functional network connectivity following cognitive rehabilitation in progressive multiple sclerosis with moderate to severe disabilty: findings from the CogEx study.

Journal of neurology·2026
Same author

Smoked Nicotine Use Is Associated with Depressive Symptoms in Women with Multiple Sclerosis.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

Looking Beyond Dose: Identifying Responders and Non-Responders to RehaCom Computerized Cognitive Rehabilitation in Progressive MS-The CogEx Study.

Neurorehabilitation and neural repair·2026
Same journal

Neuromyelitis optica spectrum disorder: a 5-year experience in a tertiary hospital in Northern Vietnam.

Multiple sclerosis and related disorders·2026
Same journal

Cell-type-specific Mendelian randomization analysis of brain single-nucleus eQTLs and neuromyelitis optica spectrum disorder risk.

Multiple sclerosis and related disorders·2026
Same journal

Detection of Aquaporin-4 antibody in cerebrospinal fluid in neuromyelitis optica spectrum disorder.

Multiple sclerosis and related disorders·2026
Same journal

Adjunctive gypenosides for acute optic neuritis: A prematurely terminated randomized, double-blind, placebo-controlled pilot trial in a cohort with frequent AQP4-IgG positivity.

Multiple sclerosis and related disorders·2026
Same journal

Genetic and molecular architecture of multiple sclerosis in gulf cooperation council populations: A scoping review and regional precision-neurology perspective.

Multiple sclerosis and related disorders·2026
Same journal

Rising burden and future projections of multiple sclerosis in East Asia: Findings from the global burden of disease study 2021.

Multiple sclerosis and related disorders·2026
See all related articles

Related Experiment Video

Updated: Apr 14, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

59.0K

Computerized cognitive testing for patients with multiple sclerosis.

Helen Lapshin1, Paul O'Connor2, Krista L Lanctôt1

  • 1Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5; University of Toronto, 27 King's College Circle, Toronto, ON, Canada M5S 1A1.

Multiple Sclerosis and Related Disorders
|April 17, 2015
PubMed
Summary
This summary is machine-generated.

Computerized cognitive testing offers a more accessible alternative to traditional methods for assessing cognitive dysfunction in multiple sclerosis (MS) patients. While promising, further research is needed for widespread implementation.

Keywords:
Automated Neuropsychology Assessment MatrixCognitionComputerized cognitive assessmentMindstreams Computerized Cognitive BatteryMultiple sclerosisNeuropsychological testing

More Related Videos

Evaluating Tests of Cognition using a Computerized Touch-Sensitive Tablet, Eye Tracking, and Functional Magnetic Resonance Imaging
10:10

Evaluating Tests of Cognition using a Computerized Touch-Sensitive Tablet, Eye Tracking, and Functional Magnetic Resonance Imaging

Published on: January 30, 2026

574
Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

8.8K

Related Experiment Videos

Last Updated: Apr 14, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

59.0K
Evaluating Tests of Cognition using a Computerized Touch-Sensitive Tablet, Eye Tracking, and Functional Magnetic Resonance Imaging
10:10

Evaluating Tests of Cognition using a Computerized Touch-Sensitive Tablet, Eye Tracking, and Functional Magnetic Resonance Imaging

Published on: January 30, 2026

574
Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

8.8K

Area of Science:

  • Neuroscience
  • Psychology
  • Medical Technology

Background:

  • Cognitive dysfunction impacts 40-65% of multiple sclerosis (MS) patients.
  • Traditional paper-and-pencil neuropsychological tests are costly and inaccessible for many.
  • Computerized cognitive testing presents a potential solution to overcome assessment barriers.

Purpose of the Study:

  • To critically review available computerized cognitive testing batteries for MS.
  • To evaluate the potential of digital tools in assessing MS-related cognitive deficits.

Main Methods:

  • Review of current computerized cognitive assessment tools.
  • Inclusion of Automated Neuropsychology Assessment Matrix (ANAM), Mindstreams Computerized Cognitive Battery (MCCB), Amsterdam Neuropsychological Tasks (ANT), Cognitive Stability Index (CSI), and Cognitive Drug Research (CDR) battery.

Main Results:

  • Several computerized batteries show promise for cognitive assessment in MS.
  • These digital tools can potentially reduce barriers to patient assessment.
  • Current findings indicate a need for further research and validation.

Conclusions:

  • Computerized cognitive testing is a developing field with potential for MS patient assessment.
  • Accessibility and cost-effectiveness are key advantages over traditional methods.
  • Further research is essential before widespread clinical adoption.